+ Reply to Thread
Page 1 of 8 1 2 3 ... LastLast
Results 1 to 10 of 76
  1. #1
    Member
    Join Date
    Sep 2012
    Posts
    74

    Default CB-03-01 - When will it come to market? Will it be a stand alone treatment?

    Could the veterans answer the above questions and also the possible long term sides from the topical. The studies suggest there are none.

    Incidentally, decade two on hair loss help was quoted as saying that it will be as effective as RU. That would be phenomenal. Can some of you opine on these matters?

  2. #2
    Member
    Join Date
    Sep 2012
    Posts
    74

    Default

    Bump Bump Bump

  3. #3
    Senior Member
    Join Date
    May 2011
    Posts
    1,046

    Default

    According to their presentation on their site (presume it's still there), the preliminary trials have shown it to be more effective than finasteride but we'll have to wait and see. I could be wrong but I thought it was going to be developed as a once a week application. Will be interesting to see what comes of it.

  4. #4
    Senior Member
    Join Date
    May 2011
    Location
    Scandinavia
    Posts
    191

    Default

    Quote Originally Posted by ammin View Post
    Could the veterans answer the above questions and also the possible long term sides from the topical. The studies suggest there are none.

    Incidentally, decade two on hair loss help was quoted as saying that it will be as effective as RU. That would be phenomenal. Can some of you opine on these matters?
    This has a long way to go before it hits the market, trials have only just begun.

    Taken from the website:

    "CB-03-01 CB-03-01, a molecule patented by Cosmo, is a steroidal ester, androgen antagonist derived from 11-deoxycortisone, which tightly mimics the profile of an ideal anti-androgen for topical use. The objective is to create a product for topical application to treat acne, male pattern baldness, and seborrhoea that does not have the side effects of products currently being taken in tablet form. An IND was filed in the US for CB-03-01 for acne. Clinical trials are planned to start in the USA in Q2 2012."

  5. #5
    Senior Member
    Join Date
    Sep 2011
    Posts
    427

    Default

    Clinical trials are already well advanced, they only just started in the US but earlier trials happened in Europe. The big downer for CB is that they are focusing on acne first, which seems bizarre since the acne market is already well supplied with viable treatments while MPB of course isn't.

    The other downer is the indicative timeline keeps slipping. I think 2017 is a realistic goal for market now.

    But in terms of efficacy and sides it's looking great. Should be a big improvement on Fin with no systemic sides, and only needs to be used once or max twice a week. And while trials are slow, at least Cosmo is making progress and getting deals done. They are also a profitable company in their own right so no worries about them going out of business if they meet delays.

  6. #6
    Senior Member
    Join Date
    Sep 2011
    Posts
    427

    Default

    It's also interesting that Cosmo STILL haven't revealed who their "US specialty pharmaceutical company" is that bought the licence for CB worldwide. We know Intrepid is conducting the US phase 2 but who coughed up $25M to Cosmo for the licencing deal? I actually wonder if it might be Allergan. They definitely fit the bill.

  7. #7
    Member
    Join Date
    Sep 2012
    Posts
    74

    Default

    I think 2015 is a more likely release date than 2017. The molecule for acne and AA topicals is the same . So the approval for AA would not take long once the approval for acne has been obtained.

    heres an email received by a hair loss help member from the Chief Medical officer at Cosmo:

    http://www.*****************/interact...Cosmo-CB-03-01


    "Dear Mr. xxx,

    I am glad to inform you that Phase II US clinical study on acne vulgaris (NCT01631474) started as planned on June 2012, and it is proceeding regularly.
    A previous Phase II European study in facial acne vulgaris (EudraCT 2008-004335-37) was completed in July 2009, and the results have been published on British Medical Journal 2011;165:177-83.
    As concerns the possible US launch, we maintain our deadline for 2015.
    Kind regards


    Giuseppe Celasco, MD
    Chief Medical Officer

    "

  8. #8
    Senior Member
    Join Date
    Sep 2011
    Posts
    427

    Default

    2015 for acne is still possible, 2016 for hair loss. I am giving it an extra year to 2017 because these things ALWAYS slip. Unfortunately they still need to do the trials for hair loss, they can't just piggyback off the acne. FDA approval requires dedicated hair loss trials. We may be able to use the acne stuff off-label but it might not be a high enough dose. It'll probably also be a cream instead of a lotion which will be hard to apply on longer hair.

    The current plan from Cosmo seems to be to finish Phase 2 for hair loss by H1/2014. Then it'll be at least 18 months to do phase 3 and get it approved. So I won't hold my breath for 2015. Will be awesome if I'm wrong though. I am really hopeful for CB, I think it has great potential to consign fin to the scrap heap.

  9. #9
    Senior Member Desmond84's Avatar
    Join Date
    Oct 2012
    Posts
    987

    Default

    Quote Originally Posted by Pate View Post
    2015 for acne is still possible, 2016 for hair loss. I am giving it an extra year to 2017 because these things ALWAYS slip. Unfortunately they still need to do the trials for hair loss, they can't just piggyback off the acne. FDA approval requires dedicated hair loss trials. We may be able to use the acne stuff off-label but it might not be a high enough dose. It'll probably also be a cream instead of a lotion which will be hard to apply on longer hair.

    The current plan from Cosmo seems to be to finish Phase 2 for hair loss by H1/2014. Then it'll be at least 18 months to do phase 3 and get it approved. So I won't hold my breath for 2015. Will be awesome if I'm wrong though. I am really hopeful for CB, I think it has great potential to consign fin to the scrap heap.
    Yeah, hopefully by 2016 we'll have the NEW big 3 which will be:

    Histogen + CB (Twice Weekly topical) + Nizoral (Twice weekly)

    That should keep everyone side effect free and happy (to an extent)

  10. #10
    Senior Member
    Join Date
    Sep 2011
    Posts
    427

    Default

    Yep! I'd even say the Big 4:

    HSC every 6-12 weeks for 1-2 years
    CB twice a week
    Nizoral twice a week
    Bimatoprost once a day

    It mightn't be a cure but it will crap all over what we have today.

Similar Threads

  1. Drug companies will stop a cure hitting the market
    By jman91 in forum Men's Hair Loss: Start Your Own Topic
    Replies: 65
    Last Post: 07-22-2022, 12:45 AM
  2. Nanogen has a new product on the market.
    By Mojo Risin in forum Cutting Edge / Future Treatments
    Replies: 9
    Last Post: 08-11-2013, 10:12 PM
  3. The Last Stand
    By TheDude in forum Men's Hair Loss: Start Your Own Topic
    Replies: 8
    Last Post: 10-28-2011, 04:12 PM
  4. Need to know where I stand (with pictures)
    By lax4life in forum Introduce Yourself & Share Your Story
    Replies: 2
    Last Post: 03-01-2011, 04:52 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts

» IAHRS

hair transplant surgeons

» The Bald Truth

» Recent Threads

1800 graft repair case results by Dr. Lindsey
Yesterday 08:38 AM
Last Post By Dr. Lindsey
Yesterday 08:38 AM
Navigating the German Job Market as a Kenyan Citizen
11-04-2023 06:31 AM
Last Post By Keegan212
Yesterday 03:51 AM
DR HAKAN DOGANAY/ 4500 GRAFTS / Implanter Pen+FUE
03-26-2024 04:15 PM
Last Post By Hakan Doganay, MD
03-26-2024 04:15 PM
The Mane Event for Thursday, June 15th, 2023
06-15-2023 02:59 PM
Last Post By gisecit34
03-26-2024 08:05 AM
Sun Exposure after Hair Transplant
02-26-2009 02:36 PM
Last Post By gisecit34
03-25-2024 08:24 PM